Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: When does cross-tolerance occur?

Cardiovascular Drugs and Therapy

Volumn 18, Issue 1, 2004, Pages 47-55

  Kośmicki, Marek Antoni ^a   Szwed, Hanna ^a   Sadowski, Zygmunt ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Exercise stress testing; Nitrate cross tolerance; Nitrate tolerance; Nitrates; Stable angina pectoris

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE;

ADULT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG CROSS TOLERANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; EVALUATION; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STABLE ANGINA PECTORIS; SUSTAINED RELEASE FORMULATION;

ADULT; ANGINA PECTORIS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG TOLERANCE; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROGLYCERIN;

EID: 3342875814     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000025755.94861.dc     Document Type: Article

References (39)

1. Fihn SD, Williams SV, Daley J, Gibbons RJ. Guidelines for the management of patients with chronic stable angina: Treatment. Ann Intern Med 2001;135:616-632.
2. Murrell W. Nitro-glycerine as a remedy for angina pectoris. Lancet 1879;1:80-81, 113-115, 225-227, 284, 642-646.
3. Wight LJ, VandenBurg MJ, Potter CE, Freeth CJ. A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris. Eur J Clin Pharmacol 1992;42:341-342.
4. Krantz JC, Carr CJ, Forman SE, et al. Mechanism and action of organic nitrates. J Pharmacol Exp Ther 1940;70: 323-327.
5. Thadani U, Fung H-L, Drake AC, et al. Oral isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 1982;49:411-419.
6. Parker J, Farrell B, Lahey K, et al. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med 1987;316:1440-1444.
7. Elkayam U. Tolerance to organic nitrates: Evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 1991;114:667-677.
8. Schelling JL, Lasagna L. A study of cross-tolerance to circulatory effects of organic nitrates. Clin Pharmacol Ther 1967;8:256-260.
9. Henry PJ, Horowitz JD, Louis WJ. Determinants of in vitro nitroglycerin tolerance induction and reversal: Influence of dose regimen, nitrate-free period, and sulfhydryl supplementation. J Cardiovasc Pharmacol 1989;14:31-37.
10. Greenberg PS, Ellestad MH, Clover RC. Comparison of the multivariate analysis and CADENZA System for determination of the probability of coronary artery disease. Am J Cardiol 1984;53:493-496.
11. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease: A meta-analysis. Circulation 1989;80:87-98.
12. Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet 2000;356:1592-1597.
13. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-315.
14. Bruce RA. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res 1971;3:323-332.
15. Glasser SP. Prospects for therapy of nitrate tolerance. Lancet 1999;353:1545-1546.
16. De la Lande IS, Stafford I, Horowitz JD. Tolerance induction by transdermal glyceryl trinitrate in rats. Eur J Pharmacol 1999;374:71-75.
17. Sage PR, De la Lande IS, Stafford I, et al. Nitroglycerin tolerance in human vessels. Evidence for impaired nitroglycerin bioconversion. Circulation 2000;102:2810-2815.
18. Fung H-L, Bauer JA. Mechanisms of nitrate tolerance. Cardiovasc Drugs Ther 1994;8:489-499.
19. Muenzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-184.
20. Fink B, Bassenge E. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate. J Cardiovasc Pharmacol 1997;30:831-836.
21. Dikalov S, Fink B, Skatchkov M, Stalleicken D, Bassenge E. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 1998;286:938-944.
22. Booth BP, Jacob S, Bauer JA, Fung H-L. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. J Cardiovasc Pharmacol 1996;28:432-438.
23. Pi X, Yan Ch, Kim D, Chen J, Berk BC. Differential expression of genes from nitrate-tolerant rat aorta. J Vasc Res 2002;39:304-310.
24. Mangione NJ, Glasser SP. Phenomenon of nitrate tolerance. Am Heart J 1994;128:137-146.
25. Bernstein LM, Ivy AC. Inosital and mannitol hexanitrates in hypertension management. Circulation 1955;12:353-360.
26. Zimrin D, Reichek N, Bogin KT, et al. Antianginal effect of intravenous nitroglycerin over 24 hours. Circulation 1988;77:1376-1384.
27. Molina CR, Andresen JW, Rapoport RM, Waldman S, Murad F. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 1987;10:371-378.
28. Muenzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression. NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res 2000;86:E7-E12.
29. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. An overview. Circ Res 2002;90:21-28.
30. De Gavarilla L, Volberg ML, Pratt PF, Silver PJ, Buchholz RA. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats. Eur J Pharmacol 1993;234:77-82.
31. Du ZY, Buxton BF, Woodman OL. Tolerance to glyceryl trinitrate in isolated human internal mammary arteries. J Thorac Cardiovasc Surg 1992;104:1280-1284.
32. Henry PJ, Horowitz JD, Louis WJ. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. J Cardiovasc Pharmacol 1990;15:365-370.
33. Keimer R, Stutzer FK, Tsikas D, Troost R, Gutzki F-M, Froelich JC. Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: A randomized, double-blind crossover study. J Cardiovasc Pharmacol 2003;41:284-292.
34. Schneeweiss A. Cross-tolerance to the antianginal effect of sublingual nitroglycerin in patients treated with long-acting nitrates. In: Schneeweiss A, ed. Cardiovascular Drug Therapy. Nitrate Therapy. Berlin, Heidelberg: Springer-Verlag, 1990:34-37.
35. Danahy DT, Aronow WS. Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 1977;56:205-212.
36. Muff Munk K, Nielsen-Kudsk JE, Sorensen KE. Nitrate tolerance: Non-invasive assessment using brachial and mitral Doppler ultrasonography. Eur Heart J 1999;20(Abstr Suppl):545, Abstr. P2865.
37. Dalal JJ, Yao L, Parker JO. Nitrate tolerance: Influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol 1983;2:115-120.
38. Dalal JJ, Parker JO. Nitrate cross-tolerance: Effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy. Am J Cardiol 1984;54:286-288.
39. Shilo L, Hadari R, Kovatz S, Qasim M, Shenkman L. Appropriateness of nitrate use in a general medicine population. Ann Pharmacother 2001;35:1339-1342.